These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10335748)

  • 1. Changes in inpatient mental health utilization and costs in a privately insured population, 1993 to 1995.
    Leslie DL; Rosenheck R
    Med Care; 1999 May; 37(5):457-68. PubMed ID: 10335748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting to outpatient care? Mental health care use and cost under private insurance.
    Leslie DL; Rosenheck R
    Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of mental health utilization and costs among children in a privately insured population.
    Leslie DL; Rosenheck RA; Horwitz SM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):113-27. PubMed ID: 11324739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care utilization and costs among privately insured patients with bipolar I disorder.
    Bryant-Comstock L; Stender M; Devercelli G
    Bipolar Disord; 2002 Dec; 4(6):398-405. PubMed ID: 12519100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient treatment of comorbid psychiatric and substance abuse disorders: comparison of public sector and privately insured populations.
    Leslie DL; Rosenheck R
    Adm Policy Ment Health; 1999 Mar; 26(4):253-68. PubMed ID: 10431398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.
    Burke JP; Hunsche E; Régulier E; Nagao M; Buzinec P; Drake Iii W
    Am J Manag Care; 2015 Jan; 21(3 Suppl):s47-58. PubMed ID: 25734573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance expenditures on bipolar disorder: clinical and parity implications.
    Peele PB; Xu Y; Kupfer DJ
    Am J Psychiatry; 2003 Jul; 160(7):1286-90. PubMed ID: 12832243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare cost, service use and mortality in major psychiatric disorders in Taiwan.
    Pan YJ; Kuo KH; Yeh LL
    J Affect Disord; 2019 Mar; 246():112-120. PubMed ID: 30580196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.
    Dusetzina SB; Farley JF; Weinberger M; Gaynes BN; Sleath B; Hansen RA
    Psychiatr Serv; 2012 Oct; 63(10):1019-25. PubMed ID: 22855210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric inpatient expenditures and public health insurance programmes: analysis of a national database covering the entire South Korean population.
    Chung W
    BMC Health Serv Res; 2010 Sep; 10():263. PubMed ID: 20819235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and utilization of substance abuse care in a privately insured population under managed care.
    Schoenbaum M; Zhang W; Sturm R
    Psychiatr Serv; 1998 Dec; 49(12):1573-8. PubMed ID: 9856619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focused psychiatric review: impacts on expense and utilization.
    Gotowka TD; Smith RB
    Benefits Q; 1991; 7(4):73-81. PubMed ID: 10170927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
    Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
    Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in mental health insurance benefits and out-of-pocket spending.
    McKusick DR; Mark TL; King EC; Coffey RM; Genuardi J
    J Ment Health Policy Econ; 2002 Jun; 5(2):71-8. PubMed ID: 12529560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of cross-sectoral treatment models on patients with mental disorders in Germany: study protocol of a nationwide long-term evaluation study (EVA64).
    Neumann A; Swart E; Häckl D; Kliemt R; March S; Küster D; Arnold K; Petzold T; Baum F; Seifert M; Weiß J; Pfennig A; Schmitt J
    BMC Psychiatry; 2018 May; 18(1):139. PubMed ID: 29776348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.